[The pediatric population as a whole, and those with special health care needs especially, is increasing.]

Peter Almgren1, Lars Gelander2, Mikael Kjerfve3

  • 1Barnläkare, Västra Götalandsregionen.

Lakartidningen
|December 17, 2020
PubMed

Insights

A significant percentage of pediatric patients require extensive healthcare. This study highlights the broad spectrum of chronic diseases and increasing special health care needs in children.

Area of Science:

  • Pediatric healthcare research
  • Public health surveillance
  • Chronic disease epidemiology

Background:

  • Understanding the prevalence of chronic conditions in children is crucial for healthcare planning.
  • The healthcare needs of pediatric populations are evolving, necessitating updated assessments.
  • Västra Götalandsregionen, Sweden, serves as the study setting.

Purpose of the Study:

  • To determine the incidence of chronic diseases in the pediatric population.
  • To quantify the extent of long-term and extensive healthcare contact among children.
  • To identify trends in special healthcare needs within the pediatric demographic.

Main Methods:

  • Utilized a dual-method approach combining clinical judgment with healthcare production register data.
  • Analyzed data from pediatric patients within Västra Götalandsregionen, Sweden.
  • Defined chronic diseases across a wide spectrum of up to 20 diagnostic areas.

Main Results:

  • Approximately 20% of pediatric patients experienced long-term or extensive healthcare engagement.
  • A broad range of chronic diseases was identified within the study cohort.
  • An increasing trend in the number of children with special healthcare needs was observed over time.

Conclusions:

  • The incidence of chronic illness and complex healthcare needs among children and adolescents is substantial.
  • Healthcare systems must adapt to the growing and diverse needs of pediatric patients with chronic conditions.
  • The findings underscore the importance of comprehensive care strategies for pediatric populations.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
109
Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
135
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
110
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
110
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
90